Ozempic-class GLP-1 drugs linked to 30% lower breast cancer odds in study of 110,000 women
- Posted on June 15, 2026
- By Bing News
- 0 Views
- 1 min read
Ozempic-class GLP-1 drugs linked to 30% lower breast cancer odds in study of 110,000 women
"They weren't designed for cancer therapy, but they do affect many different targets."